Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Novavax, Inc. shares valued at $105,675 were sold by YOUNG JAMES F on Jun 21 ’24. At $14.09 per share, YOUNG JAMES F sold 7,500 shares. The insider’s holdings dropped to 61,760 shares worth approximately $0.79 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, YOUNG JAMES F sold 7,500 shares, netting a total of over 102,881 in proceeds. Following the sale of shares at $13.72 each, the insider now holds 69,260 shares.
Before that, Dubovsky Filip had sold 13,904 shares from its account. In a trade valued at $201,164, the President, R&D traded Novavax, Inc. shares for $14.47 each. Upon closing the transaction, the insider’s holdings decreased to 13,904 shares, worth approximately $0.85 million.
As published in a research note from JP Morgan on May 10, 2024, Novavax, Inc. [NVAX] has been rated up from an Underweight to a Neutral. Analysts at BofA Securities upgraded the stock from ‘”an Underperform”‘ to ‘”a Neutral”‘ outlook in a report released in early May. As of August 09, 2023, B. Riley Securities has increased its “Neutral” rating to a “Buy” for NVAX. Earlier on April 20, 2023, TD Cowen downgraded its rating. Their new recommendation was “a Market perform” for NVAX stock which previously was a “an Outperform”.
Analyzing NVAX Stock Performance
During the last five days, there has been a drop of approximately -8.75%. Over the course of the year, Novavax, Inc. shares have jumped approximately 167.29%. Shares of the company reached a 52-week high of $23.86 on 06/06/24 and a 52-week low of $3.53 on 02/05/24. A 50-day SMA is recorded $11.37, while a 200-day SMA reached $6.96. Nevertheless, trading volume fell to 4.71 million shares from 9.42 million shares the previous day.
Support And Resistance Levels for Novavax, Inc. (NVAX)
According to the 24-hour chart, there is a support level at 12.63, which, if violated, would cause prices to drop to 12.43. In the upper region, resistance lies at 13.17. The next price resistance is at 13.51. RSI (Relative Strength Index) is 43.54 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.41, which suggests the price will decrease in the coming days. Percent R is at 99.11%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
